Brain scan breakthrough: new tracer could catch Parkinson's early
NCT ID NCT06738862
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested a new radioactive tracer called [18F] - FD17 for PET imaging to detect clumps of a protein called alpha-synuclein in the brain. These clumps are linked to Parkinson's disease, multiple system atrophy, and a sleep disorder that often precedes Parkinson's. Researchers scanned 55 people, including healthy volunteers and patients, to see if the tracer could help diagnose these conditions earlier and more accurately. The goal is to improve early detection and diagnosis of neurodegenerative diseases.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
[18F] - FD17 (a radioactive imaging agent used in PET scans)
What this could lead to
If successful, this imaging method could allow doctors to detect Parkinson's and related diseases earlier and more accurately, potentially before symptoms worsen.
What could go wrong
This is a small, completed imaging study, not a treatment trial. The agent may not reliably distinguish between different diseases, and further larger studies are needed to confirm its usefulness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China